Dow Wilson - Agilent Technologies Independent Director

A Stock  USD 145.51  1.86  1.26%   

Director

Mr. Dow R. Wilson serves as Independent Director of the Company effective March 20, 2018 since 2018.
Age 61
Tenure 6 years
Address 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
Phone800 227 9770
Webhttps://www.agilent.com
Wilson has served as president and chief executive officer of Varian Medical Systems, Inc. since September 2012. Prior to that, Mr. Wilson served in various capacities with Varian, including executive vice president and chief operating officer from October 2011 to September 2012 and vice president Varian Medical and president of Varian Medical Oncology Systems business from January 2005 to September 2011. Prior to joining Varian Medical in 2005, Mr. Wilson held various senior management positions with GE Healthcare, a diversified industrial company.

Dow Wilson Latest Insider Activity

Tracking and analyzing the buying and selling activities of Dow Wilson against Agilent Technologies stock is an integral part of due diligence when investing in Agilent Technologies. Dow Wilson insider activity provides valuable insight into whether Agilent Technologies is net buyers or sellers over its current business cycle. Note, Agilent Technologies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Agilent Technologies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Agilent Technologies Management Efficiency

The company has return on total asset of 0.0785 % which means that for every 100 dollars spent on assets, it generated a profit of $0.0785. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2095 %, implying that it made 0.2095 on every $100 invested by shareholders. Agilent Technologies' management efficiency ratios could be used to measure how well Agilent Technologies manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.14, whereas Return On Assets are forecasted to decline to 0.05. At present, Agilent Technologies' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 283.8 M, whereas Total Assets are forecasted to decline to about 9.3 B.
The company has accumulated 2.73 B in total debt with debt to equity ratio (D/E) of 0.52, which looks OK as compared to the sector. Agilent Technologies has a current ratio of 1.99, which is considered satisfactory as compared to similar companies. Debt can assist Agilent Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Agilent Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Agilent Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Agilent to invest in growth at high rates of return. When we think about Agilent Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Hila KarahDarioHealth Corp
47
Stanley MeresmanGuardant Health
71
JeanLuc BelingardLaboratory
72
Supraj RajagopalanMedpace Holdings
38
Malcolm HoenleinDarioHealth Corp
73
Guy InnesVolitionrx
60
Yalon FarhiDarioHealth Corp
54
Sanders WilliamsLaboratory
69
Robert MittelstaedtLaboratory
74
Richard StoneDarioHealth Corp
64
Samir KaulGuardant Health
44
Anastasya MolodykhMedpace Holdings
27
Peter NeupertLaboratory
65
Bruce BrownMedpace Holdings
59
Glen MollerDarioHealth Corp
N/A
Julie OvertonBioAffinity Technologies Warran
N/A
Bahija JallalGuardant Health
56
Matthew NortonMedpace Holdings
30
Jeffrey DavisLaboratory
57
Ashley KeatingMedpace Holdings
N/A
Heiner DreismannMyriad Genetics
64
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 18000 people. Agilent Technologies (A) is traded on New York Stock Exchange in USA. It is located in 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 and employs 17,700 people. Agilent Technologies is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Agilent Technologies Leadership Team

Elected by the shareholders, the Agilent Technologies' board of directors comprises two types of representatives: Agilent Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agilent. The board's role is to monitor Agilent Technologies' management team and ensure that shareholders' interests are well served. Agilent Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agilent Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Philip Binns, Senior Group
Padraig McDonnell, Senior Vice President and Presidentident - Agilent CrossLab Group
Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, Agilent, President - Life Sciences and Applied Markets Group
Darlene Solomon, CTO VP
Samraat Raha, Senior Vice President, Agilent, President - Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Jenipher Dalton, Chief VP
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
John Kohl, Senior Officer
Mikael Dolsten, Independent Director
Allison Ballmer, Vice President - Strategy and Corporate Development
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President, Agilent and President - Order Fulfillment
Dow Wilson, Independent Director
Diana Chiu, Interim VP
Heidi Kunz, Independent Director
Otis Brawley, Independent Director
Dominique Grau, Senior Vice President of Human Resources and Global Communications
Susan Rataj, Independent Director
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Katharine Knobil, Chief Medical Officer.
Boon Koh, Non-Executive Independent Chairman of the Board
Robert Herbold, Independent Director
Yvonne Mackie, MD Europe

Agilent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agilent Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Agilent Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agilent Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Agilent Stock

  0.78KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.73MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.68MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.64ME 23Andme HoldingPairCorr
  0.55MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Agilent Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agilent Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agilent Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agilent Technologies to buy it.
The correlation of Agilent Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agilent Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agilent Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agilent Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Agilent Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agilent Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agilent Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agilent Technologies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.
Note that the Agilent Technologies information on this page should be used as a complementary analysis to other Agilent Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Agilent Stock analysis

When running Agilent Technologies' price analysis, check to measure Agilent Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilent Technologies is operating at the current time. Most of Agilent Technologies' value examination focuses on studying past and present price action to predict the probability of Agilent Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agilent Technologies' price. Additionally, you may evaluate how the addition of Agilent Technologies to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Agilent Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.01)
Dividend Share
0.911
Earnings Share
4.18
Revenue Per Share
22.967
Quarterly Revenue Growth
(0.06)
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilent Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.